|
1
|
Gridelli C, Rossi A, Carbone DP, Guarize
J, Karachaliou N, Mok T, Petrella F, Spaggiari L and Rosell R:
Non-Small-Cell lung cancer. Nat Rev Dis Primers.
1(15009)2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Denkçeken T and Pala E: Investigation of
key miRNAs and potential mechanisms in non-small cell lung cancer
development from chronic obstructive pulmonary disease. Gen Physiol
Biophys. 39:69–77. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rafei H, El-Bahesh E, Finianos A,
Nassereddine S and Tabbara I: Immune-Based therapies for non-small
cell lung cancer. Anticancer Res. 37:377–387. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hill A, Gupta R, Zhao D, Vankina R, Amanam
I and Salgia R: Targeted therapies in non-small-cell lung cancer.
Cancer Treat Res. 178:3–43. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Signorelli D, Giannatempo P, Grazia G,
Aiello MM, Bertolini F, Mirabile A, Buti S, Vasile E, Scotti V,
Pisapia P, et al: Patients selection for immunotherapy in solid
tumors: Overcome the naive vision of a single biomarker. Biomed Res
Int. 2019(9056417)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tutar Y: miRNA and cancer; computational
and experimental approaches. Curr Pharm Biotechnol.
15(429)2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chaudhuri K and Chatterjee R: MicroRNA
detection and target prediction: Integration of computational and
experimental approaches. DNA Cell Biol. 26:321–337. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li M, Huo X, Davuljigari CB, Dai Q and Xu
X: MicroRNAs and their role in environmental chemical
carcinogenesis. Environ Geochem Health. 41:225–247. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rak B, Marczewska JM and Wlodarski P: The
role of microRNAs in endometrial cancer and influence on future
therapy: Focusing on miRNA-21. Eur J Gynaecol Oncol. 37:599–603.
2016.PubMed/NCBI
|
|
11
|
Kumar S, Keerthana R, Pazhanimuthu A and
Perumal P: Overexpression of circulating miRNA-21 and miRNA-146a in
plasma samples of breast cancer patients. Indian J Biochem Biophys.
50:210–214. 2013.PubMed/NCBI
|
|
12
|
Mishra S, Yadav T and Rani V: Exploring
miRNA based approaches in cancer diagnostics and therapeutics. Crit
Rev Oncol Hematol. 98:12–23. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Loubaki L, Chabot D, Paré I, Drouin M and
Bazin R: miR-146a potentially promotes IVIg-mediated inhibition of
TLR4 signaling in LPS-activated human monocytes. Immunol Lett.
185:64–73. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sun P, Zhang D, Huang H, Yu Y, Yang Z, Niu
Y and Liu J: MicroRNA-1225-5p acts as a tumor-suppressor in
laryngeal cancer via targeting CDC14B. Biol Chem. 400:237–246.
2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang S, Chen X, Zhang Z and Wu Z:
MicroRNA-1225-5p inhibits the development and progression of
thyroid cancer via targeting sirtuin 3. Pharmazie. 74:423–427.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li D, Chi G, Chen Z and Jin X:
MicroRNA-1225-5p behaves as a tumor suppressor in human
glioblastoma via targeting of IRS1. Onco Targets Ther.
11:6339–6350. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang W, Wei L, Sheng W, Kang B, Wang D
and Zeng H: miR-1225-5p functions as a tumor suppressor in
osteosarcoma by targeting sox9. DNA Cell Biol. 3:78–91.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The urihttp://microRNA.orgsimplemicroRNA.org resource:
Targets and expression. Nucleic Acids Res. 36:D149–D153. 2008.
|
|
20
|
Zhang Z, Li W, Jiang D, Liu C and Lai Z:
MicroRNA-139-5p inhibits cell viability, migration and invasion and
suppresses tumor growth by targeting HDGF in non-small cell lung
cancer. Oncol Lett. 19:1806–1814. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Huang Y, Bao T, Li Z, Ji G and Zhang L:
Function of miR-200a in proliferation and apoptosis of non-small
cell lung cancer cells. Oncol Lett. 20:1256–1262. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang L, Zhao Y, Xiong W, Ye W, Zhao W and
Hua Y: MicroRNA-449a is downregulated in cervical cancer and
inhibits proliferation, migration, and invasion. Oncol Res Treat.
42:564–571. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rahman NA, Chan CM, Zakaria MI and Jaafar
MJ: Knowledge and attitude towards identification of systemic
inflammatory response syndrome (SIRS) and sepsis among emergency
personnel in tertiary teaching hospital. Australas Emerg Care.
22:13–21. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Xu Y, Deng Y, Yan X and Zhou T: Targeting
miR-375 in gastric cancer. Expert Opin Ther Targets. 15:961–972.
2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chen X, Wang A and Yue X: miR-449c
inhibits migration and invasion of gastric cancer cells by
targeting PFKFB3. Oncol Lett. 16:417–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xu Y, Chao L, Wang J and Sun Y: miRNA-148a
regulates the expression of the estrogen receptor through
DNMT1-mediated DNA methylation in breast cancer cells. Oncol Lett.
14:4736–4740. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Baltruskeviciene E, Schveigert D,
Stankevicius V, Mickys U, Zvirblis T, Bublevic J, Bublevic J,
Suziedelis K and Aleknavicius E: Down-Regulation of miRNA-148a and
miRNA-625-3p in colorectal cancer is associated with tumor budding.
BMC Cancer. 17(607)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Marin I, Ofek E, Bar J, Prisant N,
Perelman M, Avivi C, Lavy-Shahaf G, Onn A, Katz R and Barshack I:
miR-21, EGFR and PTEN in non-small cell lung cancer: An in situ
hybridisation and immunohistochemistry study. J Clin Pathol.
14(206420)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Jiang W, Xu Z, Yu L, Che J, Zhang J and
Yang J: MicroRNA-144-3p suppressed TGF-beta1-induced lung cancer
cell invasion and adhesion by regulating the src-akt-erk pathway.
Cell Biol Int. 30(1002)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chen Y, Min L, Ren C, Xu X, Yang J, Sun X,
Wang T, Wang F, Sun C and Zhang X: miRNA-148a serves as a
prognostic factor and suppresses migration and invasion through
wnt1 in non-small cell lung cancer. PLoS One.
12(e0171751)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li Y, Chen X, Xue W, Liang J and Wang L:
miR-874 inhibits cell proliferation, migration, and invasion of
glioma cells and correlates with prognosis of glioma patients.
Neuromolecular Med. 14(1007)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yu M, Yu HL, Li QH, Zhang L and Chen YX:
miR-4709 overexpression facilitates cancer proliferation and
invasion via downregulating NR3C2 and is an unfavorable prognosis
factor in colon adenocarcinoma. J Biochem Mol Toxicol.
33(e22411)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhong R, Li S, Fang K, Yang L and Wang L:
MicroRNA-1225 inhibit apoptosis of pancreatic cancer cells via
targeting JAK1. Cell Cycle. 18:990–1000. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Osmani L, Askin F, Gabrielson E and Li QK:
Current WHO guidelines and the critical role of immunohistochemical
markers in the subclassification of non-small cell lung carcinoma
(NSCLC): Moving from targeted therapy to immunotherapy. Semin
Cancer Biol. 52:103–109. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Aoki MN, Amarante MK, de Oliveira CE and
Watanabe MA: Biomarkers in non-small cell lung cancer: Perspectives
of individualized targeted therapy. Anticancer Agents Med Chem.
18:2070–2077. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Müller S, Janke F, Dietz S and Sültmann H:
Circulating microRNAs as potential biomarkers for lung cancer.
Recent Results Cancer Res. 215:299–318. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Mizuno K, Mataki H, Seki N, Kumamoto T,
Kamikawaji K and Inoue H: MicroRNAs in non-small cell lung cancer
and idiopathic pulmonary fibrosis. J Hum Genet. 62:57–65.
2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wang Z, Liu Z, Fang X and Yang H:
miR-142-5p suppresses tumorigenesis by targeting PIK3CA in
non-small cell lung cancer. Cell Physiol Biochem. 43:2505–2515.
2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Su YH, Zhou Z, Yang KP, Wang XG, Zhu Y and
Fa XE: MIR-142-5p and miR-9 may be involved in squamous lung cancer
by regulating cell cycle related genes. Eur Rev Med Pharmacol Sci.
17:3213–3220. 2013.PubMed/NCBI
|
|
40
|
Zhou CH, Ye LP, Ye SX, Li Y, Zhang XY, Xu
XY and Gong LY: Clinical significance of SOX9 in human non-small
cell lung cancer progression and overall patient survival. J Exp
Clin Cancer Res. 31(18)2012.PubMed/NCBI View Article : Google Scholar
|
